ArticleAnnals of hematology2025

Pegaspargase administration and tolerability in patients aged 55 years or older with acute lymphoblastic leukemia treated with the LAL1913 program. A subanalysis of the Campus ALL group.

Davide Lazzarotto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.